Add BrightSurf on Google Email

Psychiatrists disagree with US policy on psychoactive drugs

A national survey of US psychiatrists found discrepancies between their perceptions of certain psychoactive drugs' safety and therapeutic value and how they are categorized under the Controlled Substances Act. Psychiatrists rated psilocybin as having low misuse potential and high therapeutic potential, but it is a Schedule I drug with ...

SourceOhio State University·JournalInternational Journal of Drug Policy·TypeSurvey·DateAug 22, 2022

Scientists reveal genetic architecture underlying alcohol, cigarette abuse

Researchers at UNC School of Medicine have identified genes linked to cigarette smoking and drinking, revealing their association with other substances like cocaine. The study's computational tool, H-MAGMA, helps parse the complex genetics involved in substance abuse, providing a foundation for developing new treatments.

SourceUniversity of North Carolina Health Care·JournalMolecular Psychiatry·TypeData/statistical analysis·DateJul 19, 2022

Study of pre-teens yields surprises about alcohol, tobacco and marijuana

A new study reveals that up to 10% of pre-teen children are curious about using substances, with boys more likely than girls to be interested. Parents' rules and home access play a significant role in shaping their children's curiosity, with Black parents being more likely to set rules against substance use.

SourceMichigan Medicine - University of Michigan·JournalDrug and Alcohol Dependence Reports·TypeSurvey·DateJul 1, 2022

Adolescents more vulnerable to cannabis addiction but not other mental health risks

A new study led by UCL and King's College London researchers found that adolescents are three times more likely to develop a cannabis addiction than adults. However, they do not appear to be at increased risk of subclinical depression or anxiety. In contrast, adult users who become addicted may experience worsening mental health symptoms.

SourceUniversity College London·JournalJournal of Psychopharmacology·TypeObservational study·DateJun 30, 2022

Opioid use disorder: Flexible treatment at home proves effective

A pan-Canadian study found that prescribing buprenorphine-naloxone at home is as effective as traditional methadone treatment in reducing opioid use. The flexible model of care offers improved access and autonomy for individuals with opioid use disorder. With over 270 participants, the OPTIMA study suggests a new approach to treating t...

SourceUniversity of Montreal Hospital Research Centre (CRCHUM)·JournalAmerican Journal of Psychiatry·TypeRandomized controlled/clinical trial·DateJun 15, 2022

Individual attitudes toward heavy alcohol use is a key predictor of college student drinking

A Rutgers study suggests that individual attitudes towards heavy alcohol use are a key predictor of college student drinking. The research found that students' own attitudes towards heavy drinking, rather than peer pressure or societal norms, were more closely linked to binge-drinking frequency and alcohol-related problems.

SourceRutgers University·JournalAlcoholism Clinical and Experimental Research·DateMay 23, 2022

Medication that lowers risk of overdose underused

Less than half of Americans with opioid use disorder received a potentially lifesaving medication over a five-year period. Buprenorphine, which reduces overdose risk, was prescribed even less often for those with polysubstance use disorder, highlighting the underutilization of this effective treatment.

SourceWashU Medicine·JournalJAMA Network Open·TypeData/statistical analysis·DateMay 10, 2022

Program issuing mailed kits doubles rate of leftover opioids disposal

A study by researchers at the University of Pennsylvania School of Medicine found that mailing opioid disposal kits doubled the rate of safe disposal among patients who received them. The kits were provided to 235 patients after orthopedic or urologic procedures and resulted in the safe disposal of 480 unused tablets.

SourceUniversity of Pennsylvania School of Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateMay 6, 2022

Massachusetts jails found ‘innovative solutions’ to implement medical treatment for incarcerated individuals with opioid use disorder

Researchers found that Massachusetts' state mandate driving staff acceptance and creating an atypical flexibility to seek innovative solutions. The program showed that medication diversion was uncommon, and protocols helped ensure correct use of the medication by detainees.

SourceUniversity of Massachusetts Amherst·JournalDrug and Alcohol Dependence·TypeExperimental study·DateApr 12, 2022

Breathing restored within 10 minutes for 80% of overdose patients

A Norwegian University of Science and Technology-developed nasal spray has been tested on over 200 acute overdose patients, restoring breathing in 80% of cases within 10 minutes. The study's findings suggest the nasal spray provides enough antidote for patients to breathe on their own while minimizing the risk of triggering abstinence.

SourceNorwegian University of Science and Technology·JournalAddiction·TypeRandomized controlled/clinical trial·DateApr 7, 2022

Only 1 in 4 people needing treatment received medication for Opioid Use Disorder in past year

A study found that only 28% of individuals needing opioid use disorder treatment received medication, with significant disparities among racial and ethnic groups. The findings highlight critical gaps in treatment engagement and access to effective medications like methadone, buprenorphine, or naltrexone.

Drug use beliefs found to be strongest predictor of youth substance use

A new study from the University of Illinois suggests that whether adolescents believe drug use is wrong has twice the magnitude of impact compared to other risk and protective factors. This finding highlights the importance of instilling a negative belief about drug use in young people as a key strategy for preventing substance use.

SourceUniversity of Illinois College of Agricultural, Consumer and Environmental Sciences·JournalSubstance Use & Misuse·TypeData/statistical analysis·DateMar 22, 2022

Simultaneous use of non-benzo sleeping pills and anti-epilepsy drugs – gabapentinoids-- increases drug overdose deaths

Researchers found a significant increase in overdose deaths involving gabapentinoids and z-drugs between 2000 and 2018. The proportion of deaths increased by more than three-fold, coinciding with exponential prescription increases. Co-usage with opioids was common, with over 67% of overdose victims having both substances in their system.

SourceColumbia University's Mailman School of Public Health·JournalThe Lancet Regional Health - Americas·DateFeb 16, 2022

Hospital admission with liver cirrhosis: highest mortality rate of all chronic diseases

A nationwide study in Germany found that liver cirrhosis has the highest mortality rate among chronic diseases, with 0.94% of hospital admissions affected. The study also showed a decline in mortality rates due to improvements in Hepatitis C treatment, but an increase in non-alcoholic fatty liver disease cases.

SourceGoethe University Frankfurt·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateFeb 11, 2022

The Lancet Public Health: Substantial increase in life-saving opioid overdose intervention urgently needed in almost every US state

The study found significant gaps in naloxone access and distribution across the US, with state-specific needs varying by epidemic type and distribution pathways. Community-based and pharmacy-initiated access points were more effective in reducing fatal opioid overdoses.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateFeb 10, 2022

Ten hospitals reduced opioid prescriptions for children who underwent appendectomy through a quality improvement initiative

A quality improvement initiative at 10 US children's hospitals has led to an almost 80% reduction in opioid prescribing for children after appendectomy, without harming patient outcomes. The study used a standardized prescribing protocol and ACS NSQIP Pediatric data to minimize opioid prescriptions.

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateFeb 3, 2022

Suicides by drug overdose increased among young people, elderly people, and Black women, despite overall downward trend

A recent study found an increase in intentional drug overdose deaths among young people aged 15-24, older adults aged 75-84, and non-Hispanic Black women. Despite a downward trend in overall deaths, these subgroups saw a rise in intentional overdose death rates, with women ages 45 to 64 having the highest rates.

SourceNIH/National Institute on Drug Abuse·JournalAmerican Journal of Psychiatry·DateFeb 2, 2022

Tackling an epidemic

The opioid crisis in the US has reached epidemic levels, with over 100,000 drug overdose deaths reported for the first time. The US Centers for Disease Control and Prevention attributes the rise to abuse of synthetic opioid fentanyl and the COVID-19 pandemic.

SourceVeterans Affairs Research Communications·JournalThe Lancet·TypeCommentary/editorial·DateFeb 2, 2022

COVID-19 vaccine hesitancy linked to childhood trauma

Research suggests a strong link between childhood trauma and vaccine hesitancy, with 3 times higher rates among those who experienced 4 or more trauma types. This is associated with lower trust in health services and increased likelihood of flouting COVID-19 restrictions.

SourceBMJ Group·JournalBMJ Open·TypeObservational study·DateFeb 1, 2022

How can body weight affect the mortality risk of excessive drinkers?

A recent study published in Drug and Alcohol Dependence found that people with underweight who drink excessively may be at an even higher risk of dying from heart disease, cancer, and other causes. The researchers analyzed data on mortality risk among drinkers and non-drinkers using the CDC categories to define

SourcePenn State·JournalDrug and Alcohol Dependence·TypeObservational study·DateJan 24, 2022